FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Oncogene (2015) - Comments
pubmed: 24998847 doi: 10.1038/onc.2014.184 issn: 0950-9232 issn: 1476-5594

D-W Wu, M-C Lee, N-Y Hsu, T-C Wu, J-Y Wu, Y-C Wang, Y-W Cheng, C-Y Chen, H Lee